Posted May 16, 2012

The New York Times reports on a possible stride in prescription drugs for those suffering with rheumatoid arthritis; possible full approval of the new drug, Tofacitinib, by August.  I vote they rethink the name, but more importanly, I hope this provides the relief for those currently having to deal with injectionable medication!


Arthritis Pill From Pfizer Wins Support Of U.S. Panel


A federal advisory panel recommended approval on Wednesday of a rheumatoid arthritis pill that could offer patients an alternative to the injectable medicines already on the market, but several members expressed concern about safety and urged the Food and Drug Administration to require rigorous follow-up studies.


To continue reading the entire article click HERE

Related Posts

Leave a Reply